logo-loader

Ergomed's Richard Barfield highlights 'resilient performance' and strong momentum

Published: 12:56 21 Jul 2020 BST

Ergomed PLC's (LON:ERGO) Richard Barfield tells Proactive London's Andrew Scott they've made excellent progress in the first half of the year and adds that underlying earnings for the full-year are expected to be materially ahead of market expectations. They've reported first half revenue growth of 14.8% taking the total to £40.4mln while its order book expanded by 22% to £151.4mln in the period.

Ergomed in robust shape to keep delivering

Jonathan Curtain, the new CFO of Ergomed PLC (AIM:ERGO, ETR:2EM), discussed his background and the company's growth prospects in an interview with Proactive London. The specialist services provider to the pharmaceutical industry focuses on growth areas like rare diseases and...

on 17/5/23